GV 2016, L.P. 13D/13G Filings for Dianthus Therapeutics, Inc. (DNTH)

GV 2016, L.P. 13D and 13G filings for Dianthus Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-09
4:10 pm
Sale
2023-12-3113GDIANTHUS THERAPEUTICS INC
DNTH
GV 2016, L.P.208,697
1.400%
-3,130,440decrease
(-93.75%)
Filing